The same as active product clinical trials

Prospective, multicenter, randomized, double-blind, placebo-controlled, efficacy and safety clinical trial with subcutaneous immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma sensitized to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae

This study is testing a new allergy treatment for people with moderate to severe hay fever symptoms, sometimes with mild asthma, caused by dust mites. It aims to see if the treatment reduces symptoms and the need for medication.